Corporate Overview

Enochian Biosciences is a pre-clinical biotechnology company potentially moving to clinical by the end of 2022. The Company is committed to using its integrated platforms, which encompass innovative gene and immune therapy interventions that provide hope for cures or life-long remissions for devastating diseases. Our platforms can potentially streamline and accelerate pre-clinical, regulatory, clinical, and production pathways. Because of the relative ease of administration, our potentially groundbreaking interventions could be used worldwide.

Read more

Latest News

View all news

Latest Presentation

Latest Events

View All Events